Interleaved TMS-fMRI for Hippocampal Stimulation: Modeling Dose-Response Relationship in Amnestic Mild Cognitive Impairment (TMS-fMRI)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 2
Contacts and Locations
Study Contact
Study Contact
- Name: Lisbeth Haaheim
- Phone Number: 7853122110
- Email: lhaaheim@arizona.edu
Study Contact Backup
- Name: Yilin Liu
- Email: yilin9@arizona.edu
Study Locations
-
-
Arizona
-
Tucson, Arizona, United States, 85719
- Bioscience Research Laboratory
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 50-80 years
- MCI clinical criteria: (a) self- or informant-reported cognitive complaint; (b) preserved independence in functional abilities; and (c) absence of dementia.
- Objective cognitive impairment supported by the following measures of general cognitive function: (a) Mini-Mental State Exam (MMSE) 24-27 (inclusive); (b) Montreal Cognitive Assessment (MoCA) 18-26 (inclusive); or (c) Clinical Dementia Rating Scale score of 0.5.
- Right handed
- English speaking
- Able to attend daily intervention (Monday-Friday) for 4 days
- Not enrolled in another interventional study within 6 months prior to beginning this study
Exclusion Criteria:
- Contraindications to transcranial magnetic stimulation (TMS) or magnetic resonance imaging (MRI)
- Other neurological disorders (e.g. stroke, head injuries, or multiple sclerosis)
- Untreated depression
- Current cancer treatment or other medical problems that might independently affect cognitive function
- Clinical Dementia Rating Scale score more than 1.0
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Other: Active TBS-Sham TBS
Active TBS in block one, Sham TBS in block two
|
TMS is a non-invasive brain stimulation technique.
The primary aim of the study will be to verify the deliverability of the TMS effect on the hippocampus and determine which stimulation protocol is more beneficial to each participant.
TMS is a non-invasive brain stimulation technique.
The primary aim of the study will be to verify the deliverability of the TMS effect on the hippocampus and determine which stimulation protocol is more beneficial to each participant.
For sham, the side of the coil that does not deliver pulses will be used.
|
|
Other: Sham TBS-Active TBS
Sham TBS in block one, Active TBS in block two
|
TMS is a non-invasive brain stimulation technique.
The primary aim of the study will be to verify the deliverability of the TMS effect on the hippocampus and determine which stimulation protocol is more beneficial to each participant.
TMS is a non-invasive brain stimulation technique.
The primary aim of the study will be to verify the deliverability of the TMS effect on the hippocampus and determine which stimulation protocol is more beneficial to each participant.
For sham, the side of the coil that does not deliver pulses will be used.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Correction Rate in Memory Association Recall
Time Frame: Immediately after intervention day (block 1 day 2) and (block 2 day 2) vs. Baseline
|
Memory tasks will be implemented and measure the correct rate to assess memory function.
The scale is the Face Name Associated Memory Score, and the min/max values are 0-1.
A higher score indicates a better outcome.
|
Immediately after intervention day (block 1 day 2) and (block 2 day 2) vs. Baseline
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Brain imaging data
Time Frame: immediately after and 24 hours after intervention
|
The investigators will acquire MRI images to measure structural and functional connectivity, respectively.
|
immediately after and 24 hours after intervention
|
|
Correction rate in memory association recall
Time Frame: immediately after and 24 hours after intervention
|
Memory tasks will be implemented and measure the correct rate to assess memory function.
|
immediately after and 24 hours after intervention
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Ying-hui Chou, ScD, University of Arizona
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- R21AG077153 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.